214 related articles for article (PubMed ID: 29988738)
21. Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity.
Tian W; Zhou J; Chen M; Qiu L; Li Y; Zhang W; Guo R; Lei N; Chang L
Sci Rep; 2022 Jul; 12(1):11632. PubMed ID: 35804089
[TBL] [Abstract][Full Text] [Related]
22. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of nomograms integrating IL-37 expression, neutrophil level, and MMR status in patients with colorectal cancer.
Zhu B; Luo J; Jiang Y; Yu L; Liu M; Fu J
Cancer Med; 2018 Aug; 7(8):3682-3694. PubMed ID: 30004182
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of farnesoid X receptor may indicate poor prognosis in patients with colorectal cancer.
Zhang D; Weng S; Cui C; Dong L; Shen X
Transl Cancer Res; 2020 Jul; 9(7):4290-4296. PubMed ID: 35117795
[TBL] [Abstract][Full Text] [Related]
25. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
26. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
27. GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
Zhao Z; Gao Y; Guan X; Liu Z; Jiang Z; Liu X; Lin H; Yang M; Li C; Yang R; Zou S; Wang X
Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30029519
[No Abstract] [Full Text] [Related]
28. HIWI expression profile in cancer cells and its prognostic value for patients with colorectal cancer.
Zeng Y; Qu LK; Meng L; Liu CY; Dong B; Xing XF; Wu J; Shou CC
Chin Med J (Engl); 2011 Jul; 124(14):2144-9. PubMed ID: 21933617
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
30. Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17).
Janknecht R
Am J Transl Res; 2010 May; 2(3):223-34. PubMed ID: 20589163
[TBL] [Abstract][Full Text] [Related]
31. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
32. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
33. Pan-cancer analysis of the prognostic and immunological roles of
Liu S; Liu Y; Zhang X; Song X; Zhang B; Zhang Y
Front Genet; 2022; 13():1039440. PubMed ID: 36313454
[No Abstract] [Full Text] [Related]
34. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
Liu Y; Zhang M; Liang L; Li J; Chen YX
Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
[TBL] [Abstract][Full Text] [Related]
35. DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression.
Chen Y; Wang Q; Wang Q; Liu J; Jiang X; Zhang Y; Liu Y; Zhou F; Liu H
Front Pharmacol; 2018; 9():1558. PubMed ID: 30733679
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
38. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L
Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640
[TBL] [Abstract][Full Text] [Related]
39. MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.
Ren F; Wang L; Shen X; Xiao X; Liu Z; Wei P; Wang Y; Qi P; Shen C; Sheng W; Du X
Am J Cancer Res; 2015; 5(4):1542-52. PubMed ID: 26101717
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma.
Lu G; Shi W; Zhang Y
Front Genet; 2021; 12():721021. PubMed ID: 34925439
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
